NCT03947697

Brief Summary

Once written consent is obtained, the participant will be provided with an accelerometer to be worn for 7 days to assess current physical activity levels. Subjects will be provided with a standardized diet (55/15/30% CHO/PRO/FAT) prior to collection of pre-intervention data of insulin sensitivity. Individuals will then participate in an 8-week electrical stimulation intervention (30min/day, 3x/week) and randomized into placebo/control, NMES, resistance training combined with NMES (RT +NMES), or resistance training (RT) group (n=15 per group), followed by collection of post-intervention data. The control group will receive electrical stimulation up to sensory level, the NMES group will receive stimulation up to tolerable intensity to induce visible muscle contraction, the RT+ NMES will receive stimulation up to tolerable intensity during resistance training, and the RT group will only receive exercise training. Pre-and post-intervention data includes measurements for body composition, resting metabolic rate, VO2max, insulin sensitivity, and comprehensive blood work.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable obesity

Timeline
12mo left

Started Aug 2022

Longer than P75 for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress79%
Aug 2022Apr 2027

First Submitted

Initial submission to the registry

December 7, 2018

Completed
5 months until next milestone

First Posted

Study publicly available on registry

May 13, 2019

Completed
3.2 years until next milestone

Study Start

First participant enrolled

August 9, 2022

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 25, 2026

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2027

Last Updated

February 20, 2025

Status Verified

August 1, 2024

Enrollment Period

4.3 years

First QC Date

December 7, 2018

Last Update Submit

February 18, 2025

Conditions

Keywords

Obesity

Outcome Measures

Primary Outcomes (1)

  • Glycemic Control

    Insulin Sensitivity will be measured through repeated blood sampling during an Oral Glucose Tolerance Test and Continuous Glucose Monitoring

    8 weeks

Secondary Outcomes (2)

  • Respiratory Exchange Ratio

    8 Weeks

  • Amount of lean mass

    8 Weeks

Study Arms (4)

Control

PLACEBO COMPARATOR

Participants will receive stimulation only up to sensory level.

Device: Neuromuscular Electrical Stimulation (Sensory)

NMES

EXPERIMENTAL

Participants will receive stimulation up to maximum tolerable level.

Device: Neuromuscular Electrical Stimulation

Resistance Training

PLACEBO COMPARATOR

Participants will receive exercise training with stimulation up to sensory level.

Device: Neuromuscular Electrical Stimulation (Sensory)Other: Resistance Training

Resistance Training + NMES

EXPERIMENTAL

Participants will receive exercise training with stimulation up to maximum tolerable intensity.

Device: Neuromuscular Electrical StimulationOther: Resistance Training

Interventions

Group will receive Electrical Stimulation up to sensory level

Also known as: Control
ControlResistance Training

Group will receive Electrical Stimulation up to maximum tolerable level

Also known as: NMES Group
NMESResistance Training + NMES

Group will receive exercise training.

Resistance TrainingResistance Training + NMES

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Overweight/Obese (BMI ≥25)
  • Sedentary Lifestyle: Physical Activity Level\<1.4
  • Less than 150min/week of structured Exercise

You may not qualify if:

  • Use of anti-hypertensive, lipid-lowering or insulin sensitizing medications
  • Excessive alcohol, drug abuse, smoking
  • Pregnant Women
  • Unwilling to adhere to the study Intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Texas at El Paso

El Paso, Texas, 79968, United States

RECRUITING

Related Publications (1)

  • Apaflo JN, Narvaez G, Tomy IJ, Mossayebi A, Fatahimeiabadi Z, McAinch AJ, Thyfault JP, Min K, Jung H, Wagler AE, Bajpeyi S. Neuromuscular electrical stimulation enhances glycemic control and carbohydrate utilization in sedentary, predominantly Hispanic overweight or obese individuals with hyperglycemia. Eur J Appl Physiol. 2025 Jul 28. doi: 10.1007/s00421-025-05907-x. Online ahead of print.

MeSH Terms

Conditions

ObesityOverweightInsulin Resistance

Interventions

Resistance Training

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsHyperinsulinismGlucose Metabolism DisordersMetabolic Diseases

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Central Study Contacts

Sudip Bajpeyi, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 7, 2018

First Posted

May 13, 2019

Study Start

August 9, 2022

Primary Completion (Estimated)

November 25, 2026

Study Completion (Estimated)

April 30, 2027

Last Updated

February 20, 2025

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations